The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
CK14, FOXA1, and androgen receptor (AR) expression in patients (pts) with triple-negative breast cancer (TNBC).
Ayca Gucalp
No relevant relationships to disclose
Margaret D. Krasne
No relevant relationships to disclose
Kiran A. Jakate
No relevant relationships to disclose
Esther N. Drill
No relevant relationships to disclose
Yong Hannah Wen
No relevant relationships to disclose
Muzaffar Akram
No relevant relationships to disclose
Alice Y. Ho
No relevant relationships to disclose
Gaorav P. Gupta
No relevant relationships to disclose
Edi Brogi
No relevant relationships to disclose
Clifford A. Hudis
No relevant relationships to disclose
Tiffany A. Traina
No relevant relationships to disclose